Emerald Health Pharmaceuticals

Early Stage

A clinical-stage biotechnology company

Analytics

Raised to Date: Raised: $43,249,314

Aggregate Commitments $

Platform

Dalmore Group

Start Date

04/30/2020

Close Date

03/31/2021

Min. Goal

$4,000

Max. Goal

$50,000,000

Min. Investment

$4,000

Security Type

Equity - Common

Funding Type

RegA+

Price Per Share

$8.00

Rolling Commitments $

Status
Funded
Reporting Date

03/31/2021

Days Remaining
Funded
% of Min. Goal

1,081,233%

% of Max. Goal

87%

Likelihood of Max
Funded
Avg. Daily Raise

$129,102

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

San Diego, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Emerald Health Pharmaceuticals is raising funds on Dalmore Group through Reg A+ crowdfunding. It is a pharmaceutical company focused on developing its drug product candidates, EHP-101 and EHP-102. The drug candidates of Emerald Health Pharmaceuticals target multiple sclerosis, systemic sclerosis, Parkinson’s disease, and Huntington’s disease. Emerald Health Pharmaceuticals has a unique technological advantage as its patented molecules, NCEs, are based on CBD and CBG molecular architectures. James M. DeMesa founded Emerald Health Pharmaceuticals in 2017. The current crowdfunding campaign has no minimum target and a maximum target of $50,000,000. The campaign proceeds will be used for clinical studies, research and development, and general and administrative expenses.

Balance Sheet

Cash and Cash Equivalents

$17,036,840

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$513,953

Loans

$0

Property, Plant and Equipment (PP&E)

$35,068

Property and Equipment

$0

Total Assets

$21,092,332

Accounts Payable & Accrued Liabilities

$2,771,443

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$0

Total Liabilities

$8,441,635

Total Stockholders' Equity

$12,358,545

Total Liabilities and Equity

$21,092,332

Statement of Comprehensive Income Information

Total Revenues

$0

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$11,961,268

Total Interest Expenses

$0

Depreciation and Amortization

$24,596

Net Income

$-12,424,622

Earnings Per Share - Basic

$-1

Earnings Per Share - Diluted

$-1

Auditor: Deloitte & Touche LLP
Financials as of: 04/30/2020
Log in or create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Emerald Health Pharmaceuticals 07/08/2021 Self Managed - $0 Equity - Common Funded RegD 506(b)
Emerald Health Pharmaceuticals 03/31/2021 Dalmore Group - $43,249,314 Equity - Common Funded RegA+
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Emerald Health Pharmaceuticals on Dalmore Group 2021
$
Platform: Dalmore Group
Security Type: Equity - Common
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Emerald Health Pharmaceuticals on Dalmore Group 2021
View on Dalmore Group (Closed)
Bullish / Bearish
You're Bullish on Emerald Health Pharmaceuticals on Dalmore Group 2021

Thank you for your vote on Emerald Health Pharmaceuticals on Dalmore Group 2021

Bullish / Bearish
You're Bearish on Emerald Health Pharmaceuticals on Dalmore Group 2021

Thank you for your vote on Emerald Health Pharmaceuticals on Dalmore Group 2021